Evidence map›Paper›PMID 33552576›Full record

ReviewCentral European journal of urology2020

Desmopressin treatment for nocturia caused by nocturnal polyuria: practical guidelines.

Mikolaj Przydacz, Marcin Chlosta, Przemyslaw Dudek, Agnieszka Cudnoch-Jedrzejewska, Wojciech Zgliczynski, Jakub Dobruch, Artur Antoniewicz, Piotr Chlosta

Open access · greenAbstract readReview
In one paragraph

Review in Central European journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Mikolaj PrzydaczDepartment of Urology, Jagiellonian University Medical College, Cracow, Poland.
Marcin ChlostaDepartment of Urology, Jagiellonian University Medical College, Cracow, Poland.
Przemyslaw DudekDepartment of Urology, Jagiellonian University Medical College, Cracow, Poland.
Agnieszka Cudnoch-JedrzejewskaDepartment of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Wojciech ZgliczynskiDepartment of Endocrinology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Jakub DobruchDepartment of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Artur AntoniewiczDepartment of Urology, Multidisciplinary Hospital Warsaw-Międzylesie, Warsaw, Poland.
Piotr ChlostaDepartment of Urology, Jagiellonian University Medical College, Cracow, Poland.
Jagiellonian University · PLPostgraduate School of Molecular Medicine · PLMedical University of Warsaw · PLMiędzyleski Szpital Specjalistyczny w Warszawie · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDesmopressin is an effective and safe therapy for nocturia caused by nocturnal polyuria. However, many physicians are unsure about the proper diagnosis of nocturnal polyuria and the identification of patients who may benefit from desmopressin treatment. Therefore, to support urologists in their routine clinical practice, the aim of this study was to provide a comprehensive paradigm for diagnosing nocturnal polyuria with recommendations for the use of desmopressin. MATERIAL AND

methodsA multidisciplinary group of experts reviewed the available literature. Findings were compiled into a practice-based approach for workup and treatment.

resultsWe designed the nocturia diagnostic pathway to confirm nocturnal polyuria, identify possible causes of nocturnal polyuria, and classify patients with indications and contraindications for desmopressin therapy. A bladder diary remains a basic diagnostic tool. Underlying conditions that may lead to nocturnal polyuria include mainly cardiac insufficiency, arterial hypertension, chronic kidney failure, obstructive sleep apnea, peripheral edema, and excessive fluid intake at night. Treatment for nocturia caused by nocturnal polyuria is based on conservative management and pharmacotherapy, but pharmacological treatment should not precede a prior attempt at conservative treatment. Before administration of desmopressin, patients should be assessed for serum sodium concentration and carefully educated about the symptoms of hyponatremia. Older individuals or persons with risk factors for the development of hyponatremia should be checked regularly for hyponatremia during desmopressin therapy.

conclusionsPeople with nocturia due to nocturnal polyuria should be evaluated carefully before initiating desmopressin treatment. Patients treated with desmopressin should be followed for both clinical efficacy and treatment-related adverse effects.

Indexed as

desmopressinguidelinenocturnal polyuriapractice

Identifiers

PMID33552576
PMCPMC7848835
OpenAlexW3126696503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.